Clinical trial
An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
NCT03368807 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
- Lead sponsor
- Eli Lilly and Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 11, 2017
- Completion date
- July 23, 2018
- Enrollment
- 79 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.